A phase III randomized placebo-controlled trial to evaluate efficacy and safety of romosozumab in men with osteoporosis
Journal of Clinical Endocrinology & Metabolism | Sep 12, 2018
A 10-year prospective study of bone mineral density and bone turnover in males and females with type 1 diabetes
Journal of Clinical Endocrinology & Metabolism | Sep 12, 2018
Statin use is associated with decreased osteoporosis and fracture risks in stroke patients
Journal of Clinical Endocrinology & Metabolism | Sep 12, 2018
Bone mass, microstructure, and strength can discriminate vertebral fracture in patients on long-term steroid treatment
Journal of Clinical Endocrinology & Metabolism | Sep 12, 2018
ACTIVExtend: 24 months of alendronate after 18 months of abaloparatide or placebo for postmenopausal osteoporosis
Journal of Clinical Endocrinology & Metabolism | Aug 12, 2018